A detailed history of Gts Securities LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gts Securities LLC holds 78,700 shares of EXAS stock, worth $3.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
78,700
Previous 75,800 3.83%
Holding current value
$3.33 Million
Previous $5.61 Million 3.07%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $182,990 - $239,900
-3,252 Reduced 3.66%
85,636 $5.91 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $3.42 Million - $4.38 Million
57,892 Added 186.77%
88,888 $6.58 Million
Q3 2023

Nov 15, 2023

BUY
$65.94 - $99.04 $1.78 Million - $2.67 Million
27,004 Added 676.45%
30,996 $2.11 Million
Q2 2023

Aug 15, 2023

BUY
$62.68 - $95.05 $250,218 - $379,439
3,992 New
3,992 $375 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.48B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.